To study the molecular mechanisms driving the pathogenesis and identify novel therapeutic targets of late onset Alzheimer's Disease (LOAD), we performed an integrative network analysis of whole-genome DNA and RNA sequencing profiling of four cortical areas, including the parahippocampal gyrus, across 364 donors spanning the full spectrum of LOAD-related cognitive and neuropathological disease severities. Our analyses revealed thousands of molecular changes and uncovered for the first-time multiple neuron specific gene subnetworks most dysregulated in LOAD. ATP6V1A, a critical subunit of vacuolar-type H + -ATPase (v-ATPase), was predicted to be a key regulator of one neuronal subnetwork and its role in disease-related processes was evaluated through CRISPR-based manipulation of human induced pluripotent stem cell derived neurons and RNAi-based knockdown in transgenic Drosophila models. This study advances our understanding of LOAD pathogenesis by providing the global landscape and detailed circuits of complex molecular interactions and regulations in several key brain regions affected by LOAD and the resulting network models provide a blueprint for developing next generation therapeutics against LOAD.
INTRODUCTION
Sporadic Late Onset Alzheimer's Disease (LOAD), the most prevalent form of dementia among people over age 65, is a progressive and irreversible brain disorder. Over 5.5 million living in the US are affected by LOAD, which is currently the sixth leading cause of death in the US, and costs more than $200 billion annually 1 . There is an urgent need to develop effective methods to prevent, treat, or delay the onset or progression of LOAD. The causes of LOAD are poorly understood, with numerous intrinsic and extrinsic factors believed to influence when the disease occurs and how it progresses. Conventional genetic and genome-wide association studies (GWAS) derived primarily from single-nucleotide polymorphism (SNP) analysis have revealed ~30 loci associated with LOAD [2] [3] [4] [5] , and almost 40% of the total phenotypic variance can be explained by these common SNPs 6 . Translating these genetic findings into biologically meaningful mechanisms of disease pathogenesis and therapeutic interventions remains a huge challenge. A number of studies have performed large-scale molecular profiling (e.g. transcriptomics, proteomics and metabolomics) of postmortem brains from normal control and LOAD patients 7, 8 . Integrating these more functionally relevant datasets holds promise for improving our understanding of the molecular mechanisms of the pathogenesis in sporadic LOAD 9 .
Leveraging cutting-edge, high-throughput molecular profiling techniques, we recently 10 generated a cohort of matched whole-genome sequencing (WGS), whole-exome sequencing (WES), and RNA-sequencing (RNA-seq) data across four brain regions, along with proteomics data generated in one of the regions, from a set of 364 well-characterized brains spanning the full spectrum of LOAD-related cognitive and neuropathological disease severities represented in the Mount Sinai Brain Bank (MSBB) 8, 11 . Systems biology approaches have proven effective for integrating large-scale and diverse biomedical data 12 , and so this MSBB-AD cohort study offers an unprecedented opportunity to develop more plausible and objective mechanistic models of LOAD. Here we employed a network biology framework to integrate high-dimensional, largescale DNA, RNA, and clinical data in LOAD to identify predictive molecular signatures and subnetworks underlying early-and late-stage LOAD. The core of our integrative analysis included genetic association, differential expression, correlation, co-expression network 13 , and causal network 14, 15 analyses, which together provided an unbiased prediction of novel causal genes and pathways of AD. While the results confirmed some key findings such as elevated immune response from the previous studies of AD 12 , our current study also uncovered a number of new subnetworks and molecular drivers underlying LOAD pathogenesis. This unique collection of multi-Omic LOAD data in tandem with the integrative network biology approaches allowed us to: 1) identify functional pathways dysregulated in LOAD with respect to multiple cognitive/neuropathological outcomes, 2) uncover and prioritize intrinsic co-expressed gene modules across a spectrum of disease stages of LOAD, 3) construct Bayesian probabilistic causal gene regulatory networks by integrating expression quantitative trait loci (eQTLs), transcription factor (TF) and gene expression data, 4) infer the key network hub genes driving key pathways of LOAD, and 5) validate the top ranked novel driver gene by characterizing its functional roles across human induced pluripotent stem cell (hiPSC)-derived neurons and fly models of LOAD ( Fig. 1A) .. 6 The MSBB-AD cohort included 364 human brains accessed from the Mount Sinai/JJ Peters VA Medical Center Brain Bank 8, 10, 11 . The age at the time of death (AOD) of the present population ranged from 61 to 108 years, with a mean and standard deviation (s.d.) of 84.7±9.7. Each donor and corresponding brain sample was assessed for multiple cognitive, medical, and neurological features, including mean plaque density, Braak staging for neurofibrillary tangles (NFT) 16, 17 , clinical dementia rating (CDR) 18 , and neuropathology scale as determined by the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) protocol 19 . These four cognitive/neuropathological traits were scored as semi-quantitative features ranging from normal to severe disease stages, reflecting the continuum and divergence of pathologic and clinical diagnoses of AD beyond a simple case-control classification. Donor brains with no discernable neuropathology or only neuropathologic features characteristic of LOAD were selected. We generated over 1,900 molecular profiles from the MSBB-AD cohort brain specimens, including 1) WGS, 2) WES, and 3) RNA-seq in four brain regions with varying vulnerability to LOAD comprised of Brodmann area 10 (frontal pole, BM10-FP), Brodmann area 22 (superior temporal gyrus, BM22-STG), Brodmann area 36 (parahippocampal gyrus, BM36-PHG) and Brodmann area 44 (inferior frontal gyrus, BM44-IFG) ( Fig. 1A) . Details about the demographics of the study sample as well as data generation and quality control (QC) have been described previously 10 . Expanded details regarding the preprocessing of the RNA-seq data, including sample filtering, normalization and covariate correction, are provided in Supplementary Information (SI) (Fig.   S1 ).
RESULTS

Study population and molecular data
Identifying gene expression signatures and pathways of LOAD
Differential gene expression analysis was performed to identify genes up-or down-regulated with respect to four LOAD related neuropathological/cognitive traits in each of the four brain regions. 7 The samples were first stratified into multiple disease severity stages for each of the four semiquantitative traits and then contrasts were made among the severity stages to identify expression changes in each brain region separately (SI). The full list of DEGs is provided in Table S1 . As summarized in Fig. 1B and Fig. S2 , BM36-PHG had the largest number of differentially expressed genes (DEGs), followed by BM22-STG, BM10-FP and BM44-IFG. This is consistent with our previous pan-cortical transcriptomic analysis of LOAD brains (which were independent of the dataset described herein) in which BM36-PHG was the most impacted region in LOAD at the gene expression level 8 . Our DEG signatures were preserved (adjusted Fisher's exact test (FET) P value up to 1.0E-100) in ten publicly available AD transcriptomic studies 7, 12, [20] [21] [22] [23] [24] [25] [26] [27] (Fig.   S3 ). Because brain cell-type composition changes over the course of LOAD, we further investigated if the present expression signatures from bulk tissue RNA-seq tend to reflect celltype changes by overlapping our DEGs with a set of cell type-specific DEGs identified from single-nucleus RNA-seq (snRNA-seq) of LOAD postmortem brains 28 . As shown in Fig. S4 , we confirmed our down-regulated gene profiles were primarily preserved in down-regulated genes detected in astrocytes, neurons, oligodendrocytes and oligodendrocyte progenitor cell (OPC), while our up-regulated gene profiles were primarily preserved in up-regulated genes in astrocytes and oligodendrocytes (adjusted FET P value up to 6.5E-45), with a few minor exceptions of excitatory neuron or microglia DEGs where there was an enrichment for opposite direction of expression changes. These results demonstrate that we identified a robust set of LOAD-related gene signatures across the four brain regions profiled.
We further analyzed gene ontology (GO) and functional pathways enriched in the DEGs ( Fig. S5 and Table S2 ). As expected, multiple central nervous system (CNS) related gene sets, such as neuronal system, transmission across chemical synapses, and neuroactive ligand receptor 8 interaction, were enriched for down-regulated genes. The KEGG 29 Parkinson's and Alzheimer' disease gene sets were enriched in the genes down-regulated in demented subjects and in subjects with high plaque density in BM36-PHG. In contrast, matrisome (defined as the ensemble of extracellular matrix (ECM) and related proteins 30 ) and associated pathways were most enriched in the up-regulated DEGs in BM36-PHG, followed by immune system, interferon signaling and cytokine signaling pathways. These observations are supported by previous reports that ECM components are associated with the early stages of LOAD 31 and memory deficits in APP/PS1 transgenic mice 32 , perhaps by influencing Aβ fibrillogenesis 33, 34 . Recent genomewide association studies (GWAS) show enriched AD risk associated with genes expressed by microglia 2, [35] [36] [37] [38] , suggesting immunological mechanisms in AD pathogenesis which are consistent with our observation.
We investigated molecular interactions between brain regions by using Pearson's correlation analysis. Between 176,453 and 1,159,477 (0.03~0.22%) gene pairs showed significant inter-region correlations across the six pairs of brain regions at a conservative Bonferroni corrected P value threshold of 0.05. The correlations for the same genes between any two regions ranged from -0.19 to 0.97 (mean = 0.31 ~ 0.38, median = 0.29 ~ 0.38), indicating the presence of both highly self-correlated genes and inversely-correlated genes. The inverse correlation highlights the importance of multiregional analyses and biological process inferences that can be drawn based on functional connectivity and the complexity of regional interactome.
On the other hand, when focusing on the gene pairs from genes with consistent inter-region correlations across all possible region pairs (Table S3) protein refolding (29.95-FE, FDR = 9.71E-9)) ( Table S4 , Fig. 1C ). Inter-region correlated gene pairs in the immune response and UPR pathways were also correlated within the corresponding individual regions in the same direction, representing coordinated responses to diseaseassociated triggers within and between the four brain regions.
Identifying gene modules associated with disease in networks of LOAD brains
To elucidate the coexpression and co-regulation relationships among a large number of gene expression signatures of LOAD, we constructed region-wide gene coexpression networks using MEGENA 39 , which employs a novel network embedding technique to build up networks (e.g. Fig. 2A ) and a multi-scale clustering method to identify coexpressed gene modules (clusters).
We identified 475, 527, 441 and 423 coherent gene expression modules in BM10-FP, BM22-STG, BM36-PHG and BM44-IFG, respectively (Table S5 ). Most modules (53.9% to 67.3%) were enriched for MSigDB GO/pathway gene sets (adjusted P value < 0.05) ( Table S6 ).
To prioritize the gene modules with respect to their association to LOAD pathology, we applied an ensemble ranking metric 8 across multiple feature types ( Fig. 2B-C) , including 1) correlations between module eigengenes (i.e. the first principal component of module gene expression profile) and cognitive/pathological traits associated with LOAD, and 2) enrichment for the DEG signatures identified above. A more complete description of the information used to rank the modules is included in Table S7 . The ranking of the top 25 MEGENA modules are illustrated in Fig. 2B , with all of the top modules coming from the BM36-PHG region.
Distinct from our previous transcriptomic network analysis in an independent cohort and brain regions which prioritizes a diverse set of LOAD-related subnetworks including immune response, glutathione transferase, and cell junction, etc. 12 , the present network analysis highlights the significance of multiple neuronal/synaptic modules in driving the disease process in the MSBB-AD cohort. Nine of the top 25 modules were associated with synaptic transmission/neuronal systems, negatively correlated with disease traits, and enriched for DEG signatures down-regulated in LOAD, including M62 (ranked 1 st , denoted as #1 for simplicity) and M65 (#2), M6 (#5), M236 (#6), M64 (#7), M252 (#9), M385 (#11), M87 (#17) and M243 (#23). These nine modules, along with three other chromosomal region related modules M242 (#13), M379 (#16) and M461 (#18), showed neuron specific expression 40 (Fig. 2C) . M64 module was overrepresented with inhibitory neuron-enriched genes, while six others (M6, M87, M65, M236, M62, and M252) were overrepresented with excitatory neuron-enriched genes 41 (Table S8 ), suggesting different neuron subtypes might be involved in these modules. The topological structures for four of the top ranked neuronal/synaptic modules are shown in Fig. 2D .
A number of LOAD genetic candidate risk genes were present in these top ranked modules, such as MEF2C in the first-ranked module M62, CELF1, MADD, PLD3, PTK2B, and ZCWPW1 in the fifth-ranked module M6, and APP and SORL1 in the seventh-ranked module M64.
We further investigated whether the top ranked neuronal/synaptic modules were involved in distinct BPs by overlapping the genes of the 4 top ranked parental neuronal/synaptic modules (i.e. M6, M62, M64 and M65) onto the GO/BP hierarchy ( Fig. 2E and S6 ). All these 4 modules are enriched in synaptic signaling to different degrees, but M6 and M64 are also enriched in regulation of long-term synaptic potentiation, synaptic vesicle trafficking and localization. M64 is also enriched in learning and memory related pathways. M6 is highly enriched in exocytosis 12 Three of the present top modules, M17 (#3), M153 (#12) and M14 (#21), were enriched with immune response pathways. All were positively correlated with disease traits and enriched for up-regulated DEGs in AD. While M14 (#21) and its sub-module M153 (#12) were enriched for microglia markers, M17 (#3) was enriched for endothelial markers (Fig. 2C) . Two LOAD genetic candidate risk genes, CLU and CR1, were members of M17 while seven LOAD genetic 13 Coexpression network analysis revealed the global gene coregulatory landscape and identified synaptic transmission and neuronal system enriched modules as highly associated with LOAD pathology. To determine potential casual relationships between coexpressed genes in these top ranked modules for predicting key regulators of the corresponding pathways underlying disease initiation and progression, we constructed Bayesian probabilistic causal networks (BNs) by integrating genetics (e.g. WGS SNP variants), gene expression, and known TF-target relationships. We first mapped eQTLs by integrating the RNA-seq and WGS-based SNP genotype data. We identified more than 92,336 SNP-gene pairs that were associated locally (socalled cis-SNP-gene pair) in any brain region, with more than 66.1% shared in at least another region. Details about the identification and replication of brain region-wide eQTLs are provided in SI (see also Table S9-13 and Fig. S8-12 ). Notably the current eQTL analysis indicated marked common genetic regulation occurring across different brain regions. We applied causal inference test (CIT) 43, 44 to use eQTLs as instrumental variables to compute the probability of the possible causal regulatory chain among genes associated with the same eQTL; these causal chain probability results were incorporated as structure priors into the BN inference procedure. Fig. 3A shows the BN for BM36-PHG.
Bayesian network analysis predicts novel key drivers of synaptic transmission/neuronal system pathways implicated in LOAD
Due to limited availability of replication data, validating the BN structure is not trivial and it has been reported that replication of edge-to-edge is strongly dependent on the sample size 45 . In contrast, highly connected key driver nodes tend to be more stable than network edges 45 . Indeed, a significant number of global key drivers 46 were shared between any two BNs ( Fig. S13) . In light of these findings, we sought to examine whether publicly available experimental gene perturbation signatures of the key drivers were predicted by our networks, by testing whether the genes in these signatures were enriched for genes in the network neighborhood of the key driver 14 in our BNs. As illustrated in Fig. 3B , we demonstrated that 50~60% of the key driver perturbation signatures were enriched in the network neighborhoods of the corresponding key drivers across the four region-wide BNs, while the proportion of significantly enriched perturbation signatures decreased to 20~30% in the network neighborhood of non-driver genes.
We projected each of the nine top ranked neuronal/synaptic modules (M62, M65, M6, M236, M64, M252, M385, M87, and M243) ( Fig. 2B) onto the BM36-PHG BN and identified network key drivers that might potentially modulate a large number of nodes in these modules using the key driver analysis 46 . We identified 48 key drivers (42 unique genes) across nine modules (Table S14) , including ten key drivers that were root nodes in the BN without parental nodes (Table S15) . To further verify the root node status beyond a single region-based network, we integrated information from all four brain region-wide BNs by building a union BN, combining directed links from four region-wide BNs following previous practices 47, 48 . Two key drivers, ATP6V1A in M64 and GABRB2 in M62, remained as root nodes in this union BN. We considered these two key drivers as the most likely process initiators of the neuronal/synaptic modules underlying the LOAD pathogenesis in the current dataset. While GABRB2 exhibits a region-dependent up-or down-regulation in LOAD based on prior studies (SI), the other prioritized key driver, ATP6V1A, was more consistently downregulated across brain regions and disease stages in LOAD. This gene encodes a component (V1 subunit A, V1a) of vacuolar ATPase (v-ATPase), a multi-subunit enzyme that mediates acidification of eukaryotic intracellular organelles. v-ATPase is a component of the mTOR pathway and functions as a lysosome-associated machinery for amino acid sensing 49, 50 . A 15 potential role of ATP6V1A in neuronal development was suggested by studying de novo mutations in this gene 51 . Yet, there are no prior studies linking changes in APT6V1A expression with LOAD pathogenesis. ATP6V1A was significantly down-regulated in the BM36-PHG (-1.43 fold, P value = 1.5E-6) and BM22-STG (-1.25 fold, P value = 2.1E-3) regions of persons with dementia (CDR ≥ 1), and it was marginally down-regulated in the BM10-FP region of persons with MCI and frank dementia (CDR = 0.5) (-1.11 fold, P value < 0.098) ( Fig. 3D and Fig. S15 ).
In addition, ATP6V1A expression was negatively correlated with cognitive/neuropathological traits in BM22-STG and BM36-PHG (Spearman correlation coefficients ranges between -0.21 and -0.44 and the corresponding P values are between 5.9E-11 to 3.3E-4), suggesting downregulation of ATP6V1A was a consistent event at both early and late stages of the disease. We validated the reduced expression of ATP6V1A in LOAD brains by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot analyses using BM36 brain samples ( Fig. 3E-G ; 42% decrease at mRNA level and 35% decrease at protein level, P < 1.0E-4). Down-regulation of ATP6V1A was also previously identified in cortical neurons of the superior frontal gyrus 21 and the hippocampus CA1 area 26 of LOAD brains. In addition, it was also found to be down-regulated in the excitatory (0.8 fold, adjusted P value 2.6E-117) and inhibitory (0.83 fold, adjusted P value 6.7E-22) neurons in brains with early-pathology of LOAD compared to no-pathology brains in the ROSMAP cohort 28 . Thus, multiple lines of evidence indicate that ATP6V1A is a novel therapeutic target for LOAD. To validate the functional role of ATP6V1A in LOAD, we performed gene perturbation experiments in both in vitro (hiPSCderived neurons) and in vivo (transgenic flies) models.
Decreased neuronal activity in ATP6V1A-deficient NGN2-neurons
As ATP6V1A was both down-regulated in the LOAD brains and enriched for neuronal expression, we developed a model of hiPSC-derived neurons with reduced expression of ATP6V1A. To repress endogenous ATP6V1A expression, we utilized CRISPR inhibition (CRISPRi) 52 , in which dCas9 (dead Cas9) is fused to the transcriptional repressor of Krüppel associated box (KRAB) 53 . We designed six sgRNAs (crispr-era.stanford.edu) to target the promoter region for knockdown (KD) of the ATP6V1A gene ( Fig. 4A ; see SI for sgRNA sequences), and individually cloned each into a lentiviral vector (lentiGuide-Hygro-mTagBFP2) 52 . By qRT-PCR and western blot, we identified two sgRNAs (ATP6V1A-i1 and i2) that efficiently repressed ATP6V1A expression in NPCs from two donors stably expressing dCas9 -KRAB ( Fig. S16A-C) . Following NGN2-induction ( Fig. S16D) 54 , both ATP6V1A RNA (60~70% transcriptional repression, P < 0.001, Fig. 4B ) and protein levels (80~90% translational repression, P < 0.001, Fig. 4C-D) were significantly reduced in 21-day (D21) cultured neurons.
ATP6V1A plays a unique role in synapse function 55 . Therefore, we determined whether ATP6V1A repression influenced spontaneous neuronal electric activity. Isogenic pairs of control and ATP6V1A CRISPRi NGN2-neurons (co-cultured with human fetal astrocytes to enhance synaptic maturation) were evaluated across a panel of assays to explore their impact on synaptic function and synapse plasticity-associated proteins. We applied an Axion multi-electrode array (MEA) to assess the impact of ATP6V1A repression on population-wide neuronal activity, including frequency and coordination of network firing. Significantly reduced neuronal activity was observed following perturbations with either sgRNA (average 4.32-fold down in D21 NGN2-neurons, P < 0.01; Fig. 4E-F) . We further measured the amplitude of voltage-gated potassium (IK) and sodium current (INa) using whole-cell patch-clamp recordings (Fig. 4G-I) .
ATP6V1A KD neurons exhibited significantly smaller INa current density (P = 0.015), but no significant change in IK current ( Fig. 4G-I) . Consistent with a decrease of INa, RNA sequencing of NGN2-neurons at 21 days (detailed below) revealed significantly reduced mRNA expression of different voltage gated sodium channel subunits, such as SCN3A, SCN2A, and SCN4B (Fig.   S17) . Lastly, we observed a decrease in the number of full action potentials and increase in immature spikes (e.g. spikelets) in the ATP6V1A CRISPRi group (Fig. 4J) .
To explore the effect of ATP6V1A on synaptic components, NGN2-neurons were immunostained against the presynaptic marker SYN1 and the postsynaptic marker HOMER1 and analyzed by confocal imaging (Fig. 4K) . A significant reduction in SYN1 + puncta number following ATP6V1A CRISPRi was observed (1.1-fold down, P < 0.001; Fig. 4K-L) across two sgRNAs, whereas CRISPRi had had limited effect on HOMER1 (Fig. 4L) . Western blot assay showed similar results. A 25-45% reduction of SYN1 (P < 0.05) was observed, while HOMER1 was expressed at comparable levels regardless of CRISPRi ( Fig. 4M-N) . qRT-PCR indicated that in ATP6V1A-deficient NGN2-neurons, only presynaptic components (SYN1, vGLUT1) were significantly decreased in RNA (~20% down, P < 0.05 and ~38% down, P < 0.01, respectively AD neuronal pathology is associated with extracellular beta-amyloid (Aβ) aggregates 56 .
Aβadministration (24 hours, 5 µM) significantly decreased spontaneous neuronal activity (P < 0.05), without altering ATP6V1A gene expression ( Fig. 4O-P and Fig. S19A-C) . Moreover, ATP6V1A repression in combination with Aβ42 exposure further impaired neuronal activity (p < 0.05, Fig. 4O-P and Fig. S19B-C) .
Neuronal knockdown of Vha68-1, a fly ortholog of ATP6V1A, worsens behavioral deficits and neurodegeneration in Aβ42 flies
In addition to the in vitro validation of neuronal activity impairment by ATP6V1A deficit in hiPSC-derived neurons, we also evaluated whether there were behavior and cellular consequences caused by knocking down ortholog of ATP6V1A using transgenic Drosophila models. According to the DIOPT (DRSC Integrative Ortholog Prediction Tool), Drosophila Vacuolar H + ATPase 68kD subunit 1 (Vha68-1, CG12403) and Vha68-2 (CG3762) are the best orthologs of human ATP6V1A proteins.
We first examined the effects of neuronal KD of Vha68-1 and Vha68-2 on neuronal integrity during aging in flies. The pan-neuronal elav-GAL4 driver was used to express shRNAi targeting Vha68-1 or Vha68-2 in neurons. Since both Vha68-1 and Vha68-2 are essential genes for viability in flies and RNAi-mediated KD of Vha68-2 in neurons resulted in lethality of flies, we selected an RNAi line that could modestly reduce mRNA expression levels of Vha68-1 (Fig.   S20A ). We found that neuronal KD of Vha68-1 by itself caused modest decline in climbing ability in aged flies (Fig. S20B) .
We next examined whether neuronal KD of Vha68-1 worsened neuronal dysfunction and neurodegeneration in a transgenic Drosophila model that expresses human Aβ42 in the brain 57 .
qRT-PCR analysis detected significant reduction in mRNA expression levels of both Vha68-1 and Vha68-2 in Aβ42 fly brains ( Fig. 4Q) , suggesting that downregulation of fly orthologs of human ATP6V1A may play a role in Aβ42-mediated toxicity. The pan-neuronal elav-GAL4 driver was used to express both Aβ42 and shRNAi targeting Vha68-1 or control shRNAi in neurons. The Aβ42 flies showed age-dependent locomotor deficits assessed by the forced climbing assay 57 , which was significantly exacerbated by neuronal KD of Vha68-1 compared to control flies (Fig. 4R) . To minimize potential off-target effects of RNAi, the climbing assay was repeated in an independent transgenic line carrying shRNAi targeting a different region of Vha68-1 (Fig. S20C-E) . Although the KD efficiency of Vha68-1 by this shRNAi was weaker ( Fig. S20C) and Vha68-1 KD by itself did not cause climbing defects (Fig. S20D) , locomotor deficits in Aβ42 flies were slightly enhanced (Fig. S20E) .
In Drosophila, brain vacuolation is a morphological hallmark of neurodegeneration and neuronal expression of Aβ42 causes age-dependent appearance of vacuoles in the central neuropils and cell bodies in the fly brains 57 . We found that KD of Vha68-1 significantly worsened neurodegeneration in the neuropil region in Aβ42 fly brains (Fig. 4S) .
To further ask whether altered neuronal activity underlies toxic interactions between ATP6V1A/Vha68-1 deficiency and Aβ42 in flies, we examined mRNA expression levels of 16 genes related to synaptic activities, focusing on GABAergic and glutamatergic systems as well as ion channels ( Fig. 4T and S20F-G) . We found that mRNA expression levels of 9 out of 16 genes were significantly reduced by neuronal KD of ATP6V1A/Vha68-1 in fly brains (Fig. S20F) , while 5 out of 16 genes were significantly reduced in Aβ42 fly brains (Fig. S20G) . Three genes, including SLC1A2/Eaat1, SLC17A6-8/vGlut and ATP1A1-3/ATP, were commonly reduced in both conditions ( Fig. S20F-G) . By contrast, neuronal KD of ATP6V1A/Vha68-1 in Aβ42 flies dramatically reduced mRNA expression levels of all 16 genes compared to control ( Fig. 4T) . Of particular interest, three key driver genes including GABRA1/Grd in M62, SCN2A/para in M65 and GABBR2/(GABA-B-R2, 3) in M6 were downregulated in these fly brains, suggesting functional links between these networks and ATP6V1A/Vha68-1 in M64 module. 20 In summary, these results suggest that Vha68-1/ATP6V1A deficiency and Aβ42 synergistically downregulate key regulator genes of neuronal activity and exaggerate Aβ42- (Table S16) , the largest number among all the comparisons.
We examined the GO/pathways impacted by ATP6V1A deficit and/or Aβ treatment by employing the Gene Set Enrichment Analysis (GSEA) 58 . Fig. 5A illustrates the top GO/pathways enriched in the molecular profiles; the full list of significantly enriched MSigDB GO/pathways is provided in Table S17 . A number of GO/pathways were commonly impacted by 21 KD (KD-V vs WT-V) and Aβ treatment (WT-Aβ vs WT-V), such as up-regulation of ribosome, translation, and DNA packaging, and down-regulation of axoneme assembly and cilium movement. As expected, we found V-ATPase transport and phagosome maturation/acidification were down-regulated in KD-V vs WT-V. Consistent with the functional assay above, we noted that KD-V vs WT-V led to down-regulation of multiple synaptic and presynaptic pathways, with the down-regulation even more significant after the exposure to Aβ treatment in KD-Aβ vs WT-Aβ. In addition, it is noted that UPR and ER stress response were up-regulated in conditions with Aβ treatment.
As combination of ATP6V1A KD and Aβ treatment led to a greater amount of molecular expression change than individual factor perturbation, we explored potential synergistic effects between the two factors 59 . We first modeled the additive effect of differential expression in the individually modulated samples computationally. Hierarchical clustering of the log FCs of all genes for each contrast showed notable differences between the predicted and observed cumulative effects (including inverse differential expression of some genes) ( Fig. S22) . Similarly, competitive gene set enrichment analysis using 877 curated gene sets found strong enrichment of disorder and cellular stress gene sets following individual KD or Aβ treatment, while the KD showed further associations with cell death and negative correlation with neuronal function signatures. The latter was markedly amplified in the combinatorial modulation (Fig. 5B) . To examine these synergistic effects in more detail, we grouped genes into synergism categories based on differential expression between the additive model and the combinatorial modulation.
Genes were classified as "more" differentially expressed in the combinatorial modulation than predicted, if their logarithmic fold change differed by at least the average standard error in all samples. Most genes were altered approximately as predicted or less, while 6% (1152 genes) were more downregulated and 9% (1773 genes) were more upregulated than expected (Fig. 5C) .
Overrepresentation analysis in our curated gene sets revealed that genes more upregulated than expected from an additive model were significantly enriched for cell death and cellular stress gene sets (Fig. 5C) .
The genes in response to ATP6V1A KD and Aβ perturbation were significantly enriched in the human postmortem brain LOAD signatures identified from the current MSBB cohort as well as 10 published datasets ( Fig. 5A and Table S18 ). were up-regulated in KD-Aβ cells compared to WT-V cells. As summarized in Table S20 and exemplified in Fig. 5D , the genes surrounding ATP6V1A on the BM36-PHG BN were enriched for down-regulation signals of ATP6V1A KD with or without Aβ treatment, with the most significant enrichment coming from KD-Aβ vs WT-V (FDR 4.1E-6). In summary, the ATP6V1A deficit signature in NGN2-neurons is consistent with the predicted topological structures in the human LOAD gene networks. 23 Conventional largest scale GWAS have identified ~30 genetic susceptibility loci associated with the risk of LOAD 2-5 , but little progress has been made in translating these genetic associations into therapeutics, reflecting the low penetrance of individual pathogenic factor and the lack of knowledge regarding causal mechanisms. Here we generated multi-Omics data from multiple brain regions of a large number of LOAD and control subjects. This unique MSBB-AD cohort enabled region-wide as well as cross-region analyses of genomic changes in LOAD brains. We identified up to 126,799 cis-associated SNP-gene pairs in region-wide analysis, majority (66.1~90.7%) of which were shared between brain regions (supplementary text). However, less than 6% of the region-wide DEGs were detected to be cis-regulated (FET P value > 0.1), suggesting a lack of detectable cis-genetic regulation among the genes dysregulated in LOAD brains. This highlights the challenges in identifying the genetic regulator that may drive the transcriptomic response in LOAD. Yet, we observed a marginally significant enrichment for LOAD genetic association signals at the cis-regulating SNPs (Table S13) , warranting further investigation to link eQTLs to GWAS hits for a better interpretation of the clinical and biological relevance of the GWAS signal. In this study, cis-eQTLs were detected at two AD GWAS loci, including one region at the HLA locus and another region near gene ZCWPW1. A fine-mapping analysis which integrates eQTLs and GWAS signals with a summary-data-based Mendelian randomization (SMR) 61 method suggests that HLA-DRB1 and HLA-DRB6 are the most plausible functionally relevant targets underlying the GWAS hits at the HLA locus and PVRIG is supported as the most likely target mediating the GWAS effect at the ZCWPW1 locus. The present analysis shows that prioritized genes may not be necessarily the genes nearest to the peak SNP as reported in the association studies, indicating caution interpreting the reported candidate risk genes by GWAS and potential power of using transcriptomic data to dissect the complex genetic association signals.
DISCUSSION
The MSBB cohort contains a continuous spectrum of LOAD-related neuropathology and clinical dementia symptom, allowing for detection of molecular changes at both early and late stage of LOAD. We built coexpression networks and BNs using all samples with an aim to maximize the power to identify the most coherent regulatory relationships across disease stages.
Our integrative network analyses prioritized functional pathways (gene modules) by considering module association with the cognitive/neuropathological traits and enrichment for LOAD-related DEGs. The top-ranked modules are related to neuronal system/synaptic transmission, immune response, ECM and matrisome related, cell adhesion, etc, which is in line with our prior knowledge about the molecular feature of LOAD including reduced neuronal activity or loss of synapses 62 , alterations in synaptic adhesion 63 , dysfunction in the immune system 64 , and changes of ECM structure 31, 32 . Interestingly, a number of LOAD genetic candidate risk genes were present in these top ranked modules, including MEF2C (M62), CELF1, MADD, PLD3, PTK2B, and ZCWPW1 (M6), and APP and SORL1 (M64), CLU and CR1 (M17), and APOE, CASS4, CD33, HLA-DRB1/HLA-DRB5, INPP5D, MS4A4A/MS4A6A and TREM2 (M153 and M14). The mechanism underlying the clustering of GWAS risk genes in the top modules is unknown. One possible reason is that they express in common cell types, especially those microglia-specific genes CASS4, CD33, HLA-DRB1/HLA-DRB5, INPP5D, MS4A4A/MS4A6A and TREM2.
One of the primary goals of this paper was to discover novel pathways and genes that are central to LOAD and could be potentially pursued with therapeutic prospects. We took advantage of the coexpression networks to prioritize modules and then used BNs to predict key driver nodes that regulated a substantial network of genes disrupted in LOAD brains. By identifying process initiators (i.e. key drivers) and reactive genes, it is possible to unravel the key genetic elements modulating pathogenic molecular mechanisms 65 . Thus, we hypothesize that key drivers play prominent roles in regulating biological pathways underlying disease pathogenesis and that manipulating the key drivers might reverse the aberrant pathway activities which in turn holds promise to reverse the disease phenotypes. The integrative network analysis-based target nomination method complements the conventional genetic linkage and linkage disequilibriumbased gene mapping technique in identifying the most functionally relevant genes that could be followed in functional studies. As 9 of the top 25 modules were related to neuronal system/synaptic transmission, we highlighted such modules to be of particular relevance to LOAD pathology and clinical severity, and predicted key molecular regulators of the modules using BNs, and one top driver, ATP6V1A, was tested experimentally for its disease relevance.
ATP6V1A, an ATP-dependent proton pump, is well known for its role in the acidification of intracellular compartments such as the lysosome; morpholino-knockdown of ATP6V1A impaired acid secretion in zebrafish 66 The present transcriptomic profiles were generated from bulk brain tissues which were mixtures of different cells of different types. Since variation in cell type proportions across individuals can influence the expression pattern, a limitation with the current transcriptomic data is that the expression level change in response to external stimuli or disease state may be confounded by cell type composition. With the recent technology advancement in single-cell gene expression analysis, including single-nucleus RNA-seq (snRNA-seq), it is now possible to study diseased tissues at the single-cell level 72 . We compared our bulk-tissue derived gene profiles with a recent snRNA-seq analysis of dorsolateral prefrontal cortex (DLPFC) region of 27 LOAD patients and controls 28 and found significant preservations of our gene signatures in the snRNA-seq DEGs with the same direction of change ( Fig. S4) , despite different brain regions analyzed. This suggests that cell type proposition may have a limited impact on our gene signatures identification. Nonetheless, it is widely accepted that there exists selective regional and cell type-specific vulnerability to LOAD 8, 73 . We anticipate generating region-specific singlecell multi-Omics data of LOAD and developing cell type-specific network models will offer invaluable in-depth understanding of the cellular complexity and etiology underlying the devastating disease.
In summary, we systematically identified molecular signatures, constructed multiscale gene networks and uncovered regulators of LOAD in four brain regions. We uncovered a number of relatively independent, neuron/synaptic transmission enriched gene subnetworks that were highly dysregulated in LOAD. We validated one predicted top key driver of the dysregulated neuronal system, ATP6V1A, in silico, in vitro and in vivo, and demonstrated ATP6V1A to be a promising therapeutic candidate target for treating LOAD. Genes showing high degree of connectivity are highlighted, with font size proportional to the degree of connectivity. B, 25 top-ranked MEGENA modules. The heatmap to the left shows the module ranking (number) and GO/pathway annotation (color) in track 1, the module-trait correlation coefficients r regarding traits bbscore, CDR, CERAD, and PlaqueMean (tracks 2-5 accordingly), and FDR adjusted P values of enrichment for different sets of DEGs (track 6-24). Specifically, tracks 6-14 denote the enrichment for down-regulated DEGs from AD-vs-normal regarding bbscore, demented-vs-MCI regarding CDR, demented-vs-nondemented regarding CDR, AD-vs-normal regarding CERAD, definite AD-vsnormal regarding CERAD, medium-vs-normal regarding PlaqueMean, severe-vs-medium regarding PlaqueMean, severe-vs-mild regarding PlaqueMean, and severe-vs-normal regarding PlaqueMean, accordingly. Tracks 15-23 denote the enrichment for up-regulated DEGs from the same contrasts as the down-regulated DEGs. An additional track 24 denotes enrichment for up-regulated DEGs from mild-vsnormal regarding PlaqueMean. C, Sunburst plots showing the module hierarchy and correlation with CDR (left), and enrichment for CDR demented-vs-nondemented DEGs (middle) and enrichment for cell typespecific markers (right). Numbers 1-13 denote 13 top ranked modules as listed to the right. Cell types are denoted by abbreviations: ast, astrocytes; end, endothelial; mic, microglia; neu, neurons; oli, oligodendrocytes. D, Representative visualization of the top ranked neuronal/synaptic modules M62, M65, M6 and M64. Node color denotes whether the gene is up-regulated (red), down-regulated (blue), or no change (grey) in demented brains. Node size is proportional to the network connectivity within each module. E, Top ranked neuronal/synaptic modules enriched in GO biological process (BP) hierarchy in relation to synaptic function, neuronal development and transportation. Each node denotes a GO/BP term, with a pie-chart displaying the -log 10 (adjusted P value) of the Fisher's exact test (FET) enrichment for the 4 top ranked neuronal/synaptic modules (i.e. M6, M62, M64 and M65). The terms are grouped into general categories as indicated by different background color blocks. Arrows denote the direction from a parent term to a child term. The GO hierarchy was extracted from the R/Bioconductor package GO.db and the GO/BP annotation gene sets were obtained from the R/Bioconductor package org.Hs.eg.db. RNA-seq analysis reveals that ATP6V1A KD impacts neuronal function related pathways and ATP6V1A KD signatures are enriched in ATP6V1A regulated networks in human LOAD brains. A, Summary of top MSigDB GO/pathway gene sets and human AD signatures, including the present MSBB BM36-PHG DEGs and public AD DEGs, which were significantly enriched in molecular profiles from the perturbations of NGN2-neurons. Plus (+) and minus (-) symbols denote the sign of enrichment scores as computed by gene set enrichment analysis (GSEA). Brown color in the x-axis of the left panel highlights the neuronal and synaptic related terms. Cyan color in the x-axis of the two panels to the right highlights the down-regulated signatures. B-C, Analysis of synergistic effect between ATP6V1A KD and Aβ treatment in NGN2-neurons. B, Summary of the functional categories that are likely to be impacted by the synergistic effect between ATP6V1A KD and Aβ treatment in NGN2-neurons. C, Pie chart in the top panel shows percentages of genes that exhibit similar or more moderate differential expression (grey) following combinatorial treatment in comparison with the expected additive model, as well as genes that are more downregulated (blue) and more upregulated (red). Heat-map in the bottom panel shows over-representation analysis of those "more down" and "more up" genes with significant synergistic differential expression (FDR < 10%), ranked by significance. "More down" genes did not exhibit significant enrichment in any category. D, Genes within a path length of 3 from ATP6V1A on the BM36-PHG BN were enriched for down-regulated signals of Aβ-KD vs V-WT (GSEA normalized enrichment score = 2.3, adjusted P value = 8.3E-6). Node fill color denotes the expression change in demented brains and node border color gradient denotes the magnitude of expression change (t-statistics from -3 to 3) induced by ATP6V1A KD in Aβtreated NGN2-neurons. Genes with known symbols are labeled.
